138 related articles for article (PubMed ID: 2470425)
21. Regional concentrations of cerebral amines: effects of tranylcypromine and phenelzine.
McKim RH; Calverly DG; Dewhurst WG; Baker GB
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):783-6. PubMed ID: 6141618
[TBL] [Abstract][Full Text] [Related]
22. Regional inhibition of monoamine oxidase activity by administration of clorgyline in rat brain.
Kunimoto N; Hazama H; Kamase H; Mizukawa R
Folia Psychiatr Neurol Jpn; 1983; 37(1):101-5. PubMed ID: 6884911
[TBL] [Abstract][Full Text] [Related]
23. Lack of neurochemical evidence for neurotoxic effects of repeated cocaine administration in rats on brain monoamine neurons.
Yeh SY; De Souza EB
Drug Alcohol Depend; 1991 Jan; 27(1):51-61. PubMed ID: 1709403
[TBL] [Abstract][Full Text] [Related]
24. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
McKenna KF; Baker GB; Coutts RT; Greenshaw AJ
J Pharm Sci; 1992 Aug; 81(8):832-5. PubMed ID: 1383493
[TBL] [Abstract][Full Text] [Related]
25. 1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol depletes catecholamines in rat brain.
Liptrot J; Holdup D; Phillipson O
J Neurochem; 1993 Dec; 61(6):2199-206. PubMed ID: 7504086
[TBL] [Abstract][Full Text] [Related]
26. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
[TBL] [Abstract][Full Text] [Related]
27. Monoamine and metabolite levels in CNS regions of the P line of alcohol-preferring rats after acute and chronic ethanol treatment.
Murphy JM; McBride WJ; Lumeng L; Li TK
Pharmacol Biochem Behav; 1983 Nov; 19(5):849-56. PubMed ID: 6196794
[TBL] [Abstract][Full Text] [Related]
28. Development of monoaminergic neurotransmitters in fetal and postnatal rat brain: analysis by HPLC with electrochemical detection.
Herregodts P; Velkeniers B; Ebinger G; Michotte Y; Vanhaelst L; Hooghe-Peters E
J Neurochem; 1990 Sep; 55(3):774-9. PubMed ID: 1696620
[TBL] [Abstract][Full Text] [Related]
29. Brain concentrations of biogenic amines and their metabolites in two types of pyrogen-induced fever in rabbits.
Gardey-Levassort C; Tanguy O; Lechat P
J Neurochem; 1977 Jan; 28(1):177-82. PubMed ID: 13153
[No Abstract] [Full Text] [Related]
30. Clorgyline-induced increases in presynaptic DA: changes in the behavioral and neurochemical effects of amphetamine using in vivo microdialysis.
Segal DS; Kuczenski R; Okuda C
Pharmacol Biochem Behav; 1992 Jul; 42(3):421-9. PubMed ID: 1409775
[TBL] [Abstract][Full Text] [Related]
31. Effect of triethyltin chloride on the central aminergic neurotransmitters and their metabolites: relationship with pathophysiology of aging.
Bentue-Ferrer D; Reymann JM; Van den Driessche J; Allain H; Bagot H
Exp Aging Res; 1985; 11(3-4):137-41. PubMed ID: 2416571
[TBL] [Abstract][Full Text] [Related]
32. Epinephrine, norepinephrine, dopamine and serotonin: differential effects of acute and chronic stress on regional brain amines.
Roth KA; Mefford IM; Barchas JD
Brain Res; 1982 May; 239(2):417-24. PubMed ID: 6178468
[TBL] [Abstract][Full Text] [Related]
33. 5-HT, dopamine, norepinephrine, and related metabolites in brain of low alcohol drinking (LAD) rats shift after chronic intra-hippocampal infusion of harman.
Adell A; Myers RD
Neurochem Res; 1995 Feb; 20(2):209-15. PubMed ID: 7540261
[TBL] [Abstract][Full Text] [Related]
34. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
35. The monoamine oxidase inhibitors clorgyline and L-deprenyl also affect the uptake of dopamine, noradrenaline and serotonin by rat brain synaptosomal preparations.
Lai JC; Leung TK; Guest JF; Lim L; Davison AN
Biochem Pharmacol; 1980 Oct; 29(20):2763-7. PubMed ID: 6776961
[No Abstract] [Full Text] [Related]
36. Increased total activity in the rat after L-tryptophan plus the monoamine oxidase-A inhibitor amiflamine but not after L-tryptophan plus clorgyline.
Archer T; Fowler CJ; Fredriksson A; Lewander T; Magnusson O; Mohringe B; Söderberg U
Br J Pharmacol; 1985 Jul; 85(3):581-90. PubMed ID: 2411326
[TBL] [Abstract][Full Text] [Related]
37. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat.
Celada P; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):583-90. PubMed ID: 7689703
[TBL] [Abstract][Full Text] [Related]
38. Changes of serotonin and catecholamines are related to pharmacokinetic alterations of clomipramine in rat brain.
Fujita K; Kobayashi A; Suzuki S; Nakazawa K
Eur J Pharmacol; 1991 Nov; 204(3):227-33. PubMed ID: 1723048
[TBL] [Abstract][Full Text] [Related]
39. Reversibility of the interaction of CGP 11305 A with MAO A in vivo.
Waldmeier PC; Feldtrauer JJ; Stoecklin K; Paul E
Eur J Pharmacol; 1983 Oct; 94(1-2):101-8. PubMed ID: 6197309
[TBL] [Abstract][Full Text] [Related]
40. Changes in rat brain monoamine turnover following chronic antidepressant administration.
Sugrue MF
Life Sci; 1980 Feb; 26(6):423-9. PubMed ID: 6154860
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
